| Name | PD0332991 HCl | CAS# | 827022-32-2 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period | 1 Day | Stock | In Stock | 
| Detail
                        Product Information Palbociclib is an oral, small molecule cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, now in Phase 3 clinical development for advanced breast cancer. | 
 
                        
                    Get all suppliers by the below link:
| 2024-07-15 | PD0332991HCl Price: Inquiry | 
| 2020-01-06 | Palbociclib (PD0332991 HCl) Price: $200.0 | 
| 2025-09-17 | PD0332991 HCl Price: ¥Inquiry | 
| 2022-05-12 | Palbociclib HCl Price: $Inquiry | 
| 2023-08-31 | Palbociclib hcl Price: ¥Inquiry | 
| 2018-02-06 | PD0332991.HCl Price: ¥Inquiry | 
| 2017-11-13 | PD0332991 HCl Price: ¥Inquiry | 
| 2021-05-10 | PD0332991 HCl Price: ¥Inquiry | 
| 2017-12-16 | PD 0332991 HCl Price: ¥Inquiry | 
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
 
                            

